AMCIL Earnings Call Transcripts
Fiscal Year 2026
-
Half-year profit increased to AUD 4.1 million, but portfolio performance lagged due to underweight positions in banks and gold, and a focus on quality compounders that underperformed. Share buybacks and special dividends were used to manage capital and address NTA discounts.
Fiscal Year 2025
-
The AGM covered a year of disappointing short-term performance but reaffirmed confidence in the long-term investment approach, with special dividends paid from realized gains. The board addressed shareholder concerns, outlined ongoing marketing and portfolio strategies, and discussed key risks and market challenges.
-
Profit declined to $6.7M, with portfolio returns lagging the market at 6.4%. Dividends rose to $0.065 per share, aided by realized gains. Management remains focused on quality, long-term growth stocks and is taking a more defensive stance amid high market valuations.
-
Half-year profit declined to AUD 3.6 million, but the portfolio outperformed benchmarks and maintained its dividend. Shares trade at a discount to NTA, with management focused on quality holdings, buybacks, and capturing market opportunities amid elevated valuations and economic uncertainty.
Fiscal Year 2024
-
The meeting reviewed a solid financial year with a 20.5% portfolio return and a maintained dividend, despite a persistent share price discount to NTA. Strategic portfolio adjustments, enhanced market communication, and a focus on quality investments were discussed, with all resolutions passed by poll.
-
Profit for the year was AUD 7.5 million, with a 20.5% portfolio return, outperforming the market. Shares trade at a 13% discount to NTA, and the MER fell to 0.56%. Cautious outlook due to high valuations, with a focus on quality, founder-led companies.